Skip to main content
. 2009 Jul 11;27(6):564–571. doi: 10.1159/000228258

Table 4.

Additional neurological features of the entire cohort and each etiological class

Parkin- sonism Chorea Myoclonus Seizure ON Visual impairment Motor dysfunction Hyperreflexia Hyporeflexia Sensory changes Cerebellar dysfunction
Early
Entire cohort 31 (13) 21 (8.9) n.a. 44 (19) 14 (6) 24 (10) 47 (20) n.a. n.a. 24 (10) 75 (32)
Degenerative 11 (15) 19 (26) n.a. 3 (4.1) 1 (1.4) 2 (2.7) 7 (9.6) n.a. n.a. 5 (6.8) 11 (15)
Autoimmune/inflammatory 0 1 (2) n.a. 8 (16) 10 (20) 7 (14) 11 (22) n.a. n.a. 6 (12) 25 (50)
Vascular 1 (7) 0 n.a. 2 (14) 1 (7.1) 5 (36) 6 (43) n.a. n.a. 1 (7.1) 3 (21)
Metabolic 1 (4) 0 n.a. 9 (36) 0 6 (24) 6 (24) n.a. n.a. 4 (16) 9 (36)
Infectious 2 (18) 0 n.a. 1 (9.1) 1 (9.1) 3 (27) 2 (18) n.a. n.a. 1 (9.1) 6 (54)
Other 5 (28) 0 n.a. 8 (44) 0 0 2 (11) n.a. n.a. 2 (11) 3 (17)
Unknown 11 (25) 1 (2.3) n.a. 13 (30) 1 (2.3) 1 (2.3) 13 (30) n.a. n.a. 5 (11) 18 (41)
p 0.0004 <0.0001 n.a. <0.0001 <0.0001 <0.0001 0.03 n.a. n.a. 0.90 0.0003

At presentation
Entire cohort 34 (14) 23 (10) 20 (8.5) 46 (20) 14 (6) 29 (12) 50 (21) 61 (26) 25 (11) 24 (10) 76 (32)
Degenerative 12 (17) 20 (27) 4 (5.5) 3 (4.1) 1 (1.4) 2 (2.7) 8 (11) 11 (15) 5 (6.9) 5 (6.8) 11 (15)
Autoimmune/inflammatory 1 (2) 1 (2) 1 (2) 9 (18) 10 (20) 8 (16) 12 (24) 18 (36) 1 (2) 6 (12) 25 (50)
Vascular 1 (7) 0 0 2 (14) 1 (7.1) 6 (43) 6 (43) 8 (57) 1 (7.1) 1 (7.1) 4 (29)
Metabolic 1 (4) 0 2 (8) 9 (36) 0 8 (32) 6 (24) 4 (16) 4 (16) 4 (16) 9 (36)
Infectious 2 (18) 1 (9.1) 7 (64) 1 (9.1) 1 (1.9) 3 (27) 2 (18) 4 (36) 2 (18) 1 (9.1) 6 (54)
Other 5 (28) 0 2 (11) 8 (44) 0 0 2 (11) 3 (17) 2 (11) 2 (11) 3 (17)
Unknown 12 (27) 1 (2.3) 4 (9.1) 14 (32) 1 (2.3) 2 (4.6) 14 (32) 13 (30) 10 (23) 5 (11) 18 (41)
p 0.002 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 0.04 0.01 0.03 0.90 0.0003

Data are presented as the number of patients followed by the percentage of the relevant etiological group in parentheses.

n.a. = Data not available; ON = optic neuritis.